SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

SI-BONE, Inc.

SI-BONE specializes in minimally invasive sacroiliac joint fusion surgery with its iFuse Implant System, which is designed to stabilize and fuse the sacroiliac joint. The company provides diagnostic services, treatment options, and patient support for SI joint dysfunction.

msh id	COM:SI-BONE
symbol	SIBN
name	SI-BONE, Inc.
homepage url	https://si-bone.com
country	US
sector	Healthcare
industry	Medical - Devices
market	STOCKS
employee count	344
crunchbase url	-
linkedin url	-
founders	-

market cap	558.33M
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	0.12
growth cost of revenue	0.88
growth depreciation and amortization	3.63
growth ebitda	0.29
growth ebitda ratio	0.46
growth eps	-
growth eps diluted	-
growth general and administrative expenses	0.07
growth gross profit	0.21
growth gross profit ratio	-0.08

COM:SI-BONE

SI-BONE

Last Close

12.15

21/11 21:00

Market Cap

558.33M

Beta: -

Volume Today

244.50K

Avg: -

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	185.82M
cost of revenue	185.82M
depreciation and amortization	5.43M
ebitda	-41.5M
ebitda ratio	-0.3
eps	-1.13
eps diluted	-1.13
operating expenses	156.35M
operating income	-46.93M
operating income ratio	-0.34

accounts receivables	-2.12M
capital expenditure	-7.8M
cash at beginning of period	20.72M
cash at end of period	33.27M
inventory	20.25M
working capital ttm	191.65M

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-